MARKET DEFINITION

Cannabis inhalers may be relatively new to the marijuana accessory scene, but they have a tried-and-true form and function, so they are probably more well-known. Cannabis inhalers have a very similar appearance to asthma inhalers and perform similarly. Cannabis inhalers deliver a vapor laced with calibrated quantities of cannabinoids, which is the key distinction between them and asthma inhalers. The cannabinoids THC, CBD, or a combination of the two may be present in cannabis products, but their effects are the same whether THC, CBD, or a combination of the two are present. Aerosolized THC is delivered in precise amounts by THC inhalers.

MARKET DYNAMICS

Increasing government attempts to encourage safe product use and consumption, the availability of synthetic cannabinoids as prescription medicine, and the growing use of cannabis to treat diseases and ailments are the drivers driving the market worldwide. However, a lack of understanding about the long-term safety of cannabis used for therapeutic purposes may operate as a barrier to profit margins in the cannabis inhaler business. Furthermore, there has been an increase in government measures to promote the safe and controlled use of cannabis inhalers; numerous research programs have been financed to uncover other uses of cannabis that may assist treat various conditions.

REPORT SCOPE

The report titled “Global Cannabis Inhalers Market – Size, Share, Growth, Opportunities, and Competitive Analysis, 2022 – 2028” offers strategic visions into the global Cannabis Inhalers market along with the market size (Value in “US$ Mn”) for the historical period 2017 to 2021 and estimates for the forecast period 2022 to 2028. The RI report is an in-depth study of the global Cannabis Inhalers market with a strong focus on key market trends, vital player strategies, and market forecasts. The study also covers key market dynamics, including drivers, restraints, opportunities, challenges, and existing and upcoming pathways that help CXOs make critical business decisions effectively. The global Cannabis Inhalers Market is predicted to grow at a significant CAGR over the forecast period from 2022 to 2028.

GEOGRAPHICAL OVERVIEW

The research report includes a detailed overview of the industry comprising quantitative and qualitative information. It gives a broad overview of the worldwide market forecasts for major segments. It also includes market size and forecast projections for five key regions: North America, Europe, Asia-Pacific (APAC), South America, and the Middle East & Africa (MEA), for the years 2017 to 2028. The market is further divided by categories and countries within each province. The research scrutinizes and forecasts over 20 nations worldwide, as well as the present trend and possibilities in these regions.

MARKET SEGMENTATION

The Global Cannabis Inhalers Market is segmented based on drug type, indication, distribution channel, and region. Based on drug type, the market has been segmented into Cannbigerol (CBG), Tetrahydrocannabivarinic (THCV), Cannabidiol (CBD), and Tetrahydrocannabinol (THC), whereas based on indication, the market comprises Stress, Anxiety, Sleeping Disorders, Chronic Pain, Inflammation, Asthma, and Others. Based on distribution channel, the market has been segmented into Retail Pharmacies, Hospitals, Specialized Health Centers, and Others.

COMPETITION LANDSCAPE

The RI research report discusses noteworthy developments in the industry as well as organic and inorganic growth strategies being adopted by the Cannabis Inhalers market players. The report covers industry activities, including new product launches, mergers & acquisitions, business partnerships, and various expansion initiatives being undertaken by the active players in the market. These developments pave the path for various market participants to strengthen their positioning as well as expand their consumer base. The positive market outlook for the global Cannabis Inhalers market is anticipated to present lucrative growth opportunities to the market players. The report also offers detailed profiles of major players in the global Cannabis Inhalers market, emphasizing the strategic initiatives, financial information, SWOT analysis, and key development in the Cannabis Inhalers industry in the past three years.

Key players in the Global Cannabis Inhalers Market have adopted various organic as well as inorganic growth strategies to strengthen their market positioning. Prominent players in the market include:

• Koi CBD
• CBD Luxe
• MÜV
• Fairwinds Cannabis
• Monarch Life Sciences LLC
• Vapen Brands
• Vectura Group plc
• H&T Presspart Manufacturing Ltd.
• Syqe Medical Ltd.

COVID-19 IMPACT ANALYSIS ON GLOBAL ADAPTIVE LEARNING MARKET

The COVID-19 pandemic is still a very personal, individual experience that is also a once-in-a-lifetime worldwide phenomenon with far-reaching consequences. The epidemic has wreaked havoc on people's lives in all nations and communities and also had a negative impact on global economic development in 2020, unlike anything seen in almost a century. The pandemic severely impacted key economies such as India, Brazil, the U.S., France, Russia, the UK, Italy, Turkey, and Argentina. According to estimates, the virus slowed global economic growth by -3.4 percent to -7.6 percent in 2020, with a rebound of 4.2 percent to 5.6 percent expected in 2021. In 2020, global commerce was expected to decline by 5.3 percent, but it is expected to rise by 8.0 percent in 2021.

In contrast to the global economic downturn in the first half of 2020, the economy began to showcase symptoms of a two-track recovery post the second quarter of 2020, with a fledgling rebound in developed nations, however, slower growth in emerging economies. The outbreak of the Covid-19 pandemic has not only resulted in halted production activity but has also disrupted the global supply chain. The research goes on to evaluate the current and future implications of the COVID-19 pandemic both on the target as well as broader market, thereby, providing accurate and trustworthy forecasts.

RESEARCH PROGRAM DESIGN

KEY QUESTIONS ANSWERED

1. What is the current size of the global Cannabis Inhalers market?
2. What will be the growth rate of the market over the forecast period?
3. Who are the key manufacturers/vendors in the Cannabis Inhalers market space?
4. What are the major market opportunities and market risks faced by the market?
5. What is the impact of COVID-19 on the market?
6. What are the revenue, sales, and price analysis of the top manufacturers in this market?
7. What are the key outcomes of Porter's five forces model?
8. Who are the distributors, traders, and vendors in the industry?

REASONS FOR BUYING THIS REPORT:

• The report offers comprehensive data on the Cannabis Inhalers market elaborating on the current state and future growth prospects both globally and regionally
• It offers a six-year market forecast trend evaluating the impact of drivers and restraints and supporting factors for growth
• The report offers deep-dive insights into each market segment and critical factors responsible for its growth
• The report presents precise picture of the dynamic competitive landscape which helps our client advance their market position
• The comprehensive analysis of the market along with the inclusion of analyst recommendations ensures that our clients make informed business decisions
• Cross-segment country-level analysis included in the report which provides granular analysis of more than 20+ countries covered in the report scope
• The study includes detailed profiles of major manufacturers to help our readers gain holistic overview of the market competitors and consequently align their business strategies

Chapter 1. Executive Summary
1.1. Market Outlook
1.2. Market Segment Outlook
1.3. Geography Outlook
1.4. Absolute $ Opportunity

Chapter 2. Research Methodology
2.1. Research Approach
2.2. Scope, Definition, and Assumptions
2.3. Data Sources
2.3.1. Secondary Sources
2.3.1.1. Preliminary Data Mining
2.3.2. Primary Sources
2.3.2.1. Statistical Model
2.3.2.2. Data Triangulation
2.3.2.3. Research Objective

Chapter 3. Market Outlook
3.1. Introduction
3.2. Key Trends
3.2.1. Drug Type Trends
3.2.2. Indication Trends
3.2.3. Distribution Channel Trends
3.3. Market Dynamics
3.3.1. Market Drivers
3.3.1.1. Impact Analysis of Market Drivers
3.3.2. Market Restraints
3.3.2.1. Impact Analysis of Market Restraints
3.3.3. Market Opportunities
3.3.3.1. Impact Analysis of Market Opportunities
3.3.4. Market Challenges
3.3.4.1. Impact Analysis of Market Challenges
3.4. Porter’s Five Forces’ Analysis
3.4.1. Bargaining Power of Suppliers
3.4.2. Bargaining Power of Buyers
3.4.3. Threat of New Entrant
3.4.4. Threat of Substitutes
3.4.5. Competitive Rivalry
3.5. Value Chain Analysis: Global Cannabis Inhalers Market
3.6. COVID-19 Impact Assessment in Cannabis Inhalers Market
3.6.1. Impact Assessment on Global Cannabis Inhalers Market
3.6.2. Market Trends and Opportunities in the Covid-19 Landscape

Chapter 4. Global Cannabis Inhalers Market Overview, By Drug Type, 2017 - 2028 (USD Million)
4.1. Global Cannabis Inhalers Market Share, By Drug Type, 2017 - 2028 (USD Million)
4.1.1. Cannbigerol (CBG)
4.1.2. Tetrahydrocannabivarinic (THCV)
4.1.3. Cannabidiol (CBD)
4.1.4. Tetrahydrocannabinol (THC)

Chapter 5. Global Cannabis Inhalers Market Overview, By Indication, 2017 - 2028 (USD Million)
5.1. Global Cannabis Inhalers Market Share, By Indication, 2017 - 2028 (USD Million)
5.1.1. Stress
5.1.2. Anxiety
5.1.3. Sleeping Disorders
5.1.4. Chronic Pain
5.1.5. Inflammation
5.1.6. Asthma
5.1.7. Others

Chapter 6. Global Cannabis Inhalers Market Overview, By Distribution Channel, 2017 - 2028 (USD Million)
6.1. Global Cannabis Inhalers Market Share, By Distribution Channel, 2017 - 2028 (USD Million)
6.1.1. Retail Pharmacies
6.1.2. Hospitals
6.1.3. Specialized Health Centers
6.1.4. Others

Chapter 7. Global Cannabis Inhalers Market Overview, By Geography, 2017 - 2028 (USD Million)
7.1. Global Cannabis Inhalers Market Share, By Geography, 2017 - 2028 (USD Million)
7.1.1. Market Size and Projections, by Countries, 2017 - 2028 (USD Million)
7.1.2. Market Share and CAGR Comparison, by Countries, 2021 (%)

Chapter 8. North America Cannabis Inhalers Market Overview, By Countries, 2017 - 2028 (USD Million)
8.1. North America Cannabis Inhalers Market Overview, 2017 - 2028 (USD Million)
8.1.1. Market size and projections, 2017 - 2028 (USD Million)
8.1.2. North America Cannabis Inhalers Market Overview, By Drug Type, 2017 - 2028 (USD Million)
8.1.3. North America Cannabis Inhalers Market Overview, By Indication, 2017 - 2028 (USD Million)
8.1.4. North America Cannabis Inhalers Market Overview, By Distribution Channel, 2017 - 2028 (USD Million)
8.2. North America Cannabis Inhalers Market Overview, By Countries, 2017 - 2028 (USD Million)
8.2.1. U.S. Cannabis Inhalers Market Overview, 2017 - 2028 (USD Million)
8.2.1.1. U.S. Cannabis Inhalers Market Overview, By Drug Type, 2017 - 2028 (USD Million)
8.2.1.2. U.S. Cannabis Inhalers Market Overview, By Indication, 2017 - 2028 (USD Million)
8.2.1.3. U.S. Cannabis Inhalers Market Overview, By Distribution Channel, 2017 - 2028 (USD Million)
8.2.2. Canada Cannabis Inhalers Market Overview, 2017 - 2028 (USD Million)
8.2.2.1. Canada Cannabis Inhalers Market Overview, By Drug Type, 2017 - 2028 (USD Million)
8.2.2.2. Canada Cannabis Inhalers Market Overview, By Indication, 2017 - 2028 (USD Million)
8.2.2.3. Canada Cannabis Inhalers Market Overview, By Distribution Channel, 2017 - 2028 (USD Million)
8.2.3. Mexico Cannabis Inhalers Market Overview, 2017 - 2028 (USD Million)
8.2.3.1. Mexico Cannabis Inhalers Market Overview, By Drug Type, 2017 - 2028 (USD Million)
8.2.3.2. Mexico Cannabis Inhalers Market Overview, By Indication, 2017 - 2028 (USD Million)
8.2.3.3. Mexico Cannabis Inhalers Market Overview, By Distribution Channel, 2017 - 2028 (USD Million)

Chapter 9. Europe Cannabis Inhalers Market Overview, By Countries, 2017 - 2028 (USD Million)
9.1. Europe Cannabis Inhalers Market Overview, 2017 - 2028 (USD Million)
9.1.1. Market size and projections, 2017 - 2028 (USD Million)
9.1.2. Europe Cannabis Inhalers Market Overview, By Drug Type, 2017 - 2028 (USD Million)
9.1.3. Europe Cannabis Inhalers Market Overview, By Indication, 2017 - 2028 (USD Million)
9.1.4. Europe Cannabis Inhalers Market Overview, By Distribution Channel, 2017 - 2028 (USD Million)
9.2. Europe Cannabis Inhalers Market Overview, By Countries, 2017 - 2028 (USD Million)
9.2.1. Germany Cannabis Inhalers Market Overview, 2017 - 2028 (USD Million)
9.2.1.1. Germany Cannabis Inhalers Market Overview, By Drug Type, 2017 - 2028 (USD Million)
9.2.1.2. Germany Cannabis Inhalers Market Overview, By Indication, 2017 - 2028 (USD Million)
9.2.1.3. Germany Cannabis Inhalers Market Overview, By Distribution Channel, 2017 - 2028 (USD Million)
9.2.2. France Cannabis Inhalers Market Overview, 2017 - 2028 (USD Million)
9.2.2.1. France Cannabis Inhalers Market Overview, By Drug Type, 2017 - 2028 (USD Million)
9.2.2.2. France Cannabis Inhalers Market Overview, By Indication, 2017 - 2028 (USD Million)
9.2.2.3. France Cannabis Inhalers Market Overview, By Distribution Channel, 2017 - 2028 (USD Million)
9.2.3. UK Cannabis Inhalers Market Overview, 2017 - 2028 (USD Million)
9.2.3.1. UK Cannabis Inhalers Market Overview, By Drug Type, 2017 - 2028 (USD Million)
9.2.3.2. UK Cannabis Inhalers Market Overview, By Indication, 2017 - 2028 (USD Million)
9.2.3.3. UK Cannabis Inhalers Market Overview, By Distribution Channel, 2017 - 2028 (USD Million)
9.2.4. Italy Cannabis Inhalers Market Overview, 2017 - 2028 (USD Million)
9.2.4.1. Italy Cannabis Inhalers Market Overview, By Drug Type, 2017 - 2028 (USD Million)
9.2.4.2. Italy Cannabis Inhalers Market Overview, By Indication, 2017 - 2028 (USD Million)
9.2.4.3. Italy Cannabis Inhalers Market Overview, By Distribution Channel, 2017 - 2028 (USD Million)
9.2.5. Spain Cannabis Inhalers Market Overview, 2017 - 2028 (USD Million)
9.2.5.1. Spain Cannabis Inhalers Market Overview, By Drug Type, 2017 - 2028 (USD Million)
9.2.5.2. Spain Cannabis Inhalers Market Overview, By Indication, 2017 - 2028 (USD Million)
9.2.5.3. Spain Cannabis Inhalers Market Overview, By Distribution Channel, 2017 - 2028 (USD Million)
9.2.6. NORDIC Cannabis Inhalers Market Overview, 2017 - 2028 (USD Million)
9.2.6.1. NORDIC Cannabis Inhalers Market Overview, By Drug Type, 2017 - 2028 (USD Million)
9.2.6.2. NORDIC Cannabis Inhalers Market Overview, By Indication, 2017 - 2028 (USD Million)
9.2.6.3. NORDIC Cannabis Inhalers Market Overview, By Distribution Channel, 2017 - 2028 (USD Million)
9.2.7. Russia and CIS Cannabis Inhalers Market Overview, 2017 - 2028 (USD Million)
9.2.7.1. Russia and CIS Cannabis Inhalers Market Overview, By Drug Type, 2017 - 2028 (USD Million)
9.2.7.2. Russia and CIS Cannabis Inhalers Market Overview, By Indication, 2017 - 2028 (USD Million)
9.2.7.3. Russia and CIS Cannabis Inhalers Market Overview, By Distribution Channel, 2017 - 2028 (USD Million)
9.2.8. Rest of Europe Cannabis Inhalers Market Overview, 2017 - 2028 (USD Million)
9.2.8.1. Rest of Europe Cannabis Inhalers Market Overview, By Drug Type, 2017 - 2028 (USD Million)
9.2.8.2. Rest of Europe Cannabis Inhalers Market Overview, By Indication, 2017 - 2028 (USD Million)
9.2.8.3. Rest of Europe Cannabis Inhalers Market Overview, By Distribution Channel, 2017 - 2028 (USD Million)

Chapter 10. Asia Pacific Cannabis Inhalers Market Overview, By Countries, 2017 - 2028 (USD Million)
10.1. Asia Pacific Cannabis Inhalers Market Overview, 2017 - 2028 (USD Million)
10.1.1. Market size and projections, 2017 - 2028 (USD Million)
10.1.2. Asia Pacific Cannabis Inhalers Market Overview, By Drug Type, 2017 - 2028 (USD Million)
10.1.3. Asia Pacific Cannabis Inhalers Market Overview, By Indication, 2017 - 2028 (USD Million)
10.1.4. Asia Pacific Cannabis Inhalers Market Overview, By Distribution Channel, 2017 - 2028 (USD Million)
10.2. Asia Pacific Cannabis Inhalers Market Overview, By Countries, 2017 - 2028 (USD Million)
10.2.1. India Cannabis Inhalers Market Overview, 2017 - 2028 (USD Million)
10.2.1.1. India Cannabis Inhalers Market Overview, By Drug Type, 2017 - 2028 (USD Million)
10.2.1.2. India Cannabis Inhalers Market Overview, By Indication, 2017 - 2028 (USD Million)
10.2.1.3. India Cannabis Inhalers Market Overview, By Distribution Channel, 2017 - 2028 (USD Million)
10.2.2. China Cannabis Inhalers Market Overview, 2017 - 2028 (USD Million)
10.2.2.1. China Cannabis Inhalers Market Overview, By Drug Type, 2017 - 2028 (USD Million)
10.2.2.2. China Cannabis Inhalers Market Overview, By Indication, 2017 - 2028 (USD Million)
10.2.2.3. China Cannabis Inhalers Market Overview, By Distribution Channel, 2017 - 2028 (USD Million)
10.2.3. Japan Cannabis Inhalers Market Overview, 2017 - 2028 (USD Million)
10.2.3.1. Japan Cannabis Inhalers Market Overview, By Drug Type, 2017 - 2028 (USD Million)
10.2.3.2. Japan Cannabis Inhalers Market Overview, By Indication, 2017 - 2028 (USD Million)
10.2.3.3. Japan Cannabis Inhalers Market Overview, By Distribution Channel, 2017 - 2028 (USD Million)
10.2.4. ASEAN Cannabis Inhalers Market Overview, 2017 - 2028 (USD Million)
10.2.4.1. ASEAN Cannabis Inhalers Market Overview, By Drug Type, 2017 - 2028 (USD Million)
10.2.4.2. ASEAN Cannabis Inhalers Market Overview, By Indication, 2017 - 2028 (USD Million)
10.2.4.3. ASEAN Cannabis Inhalers Market Overview, By Distribution Channel, 2017 - 2028 (USD Million)
10.2.5. South Korea Cannabis Inhalers Market Overview, 2017 - 2028 (USD Million)
10.2.5.1. South Korea Cannabis Inhalers Market Overview, By Drug Type, 2017 - 2028 (USD Million)
10.2.5.2. South Korea Cannabis Inhalers Market Overview, By Indication, 2017 - 2028 (USD Million)
10.2.5.3. South Korea Cannabis Inhalers Market Overview, By Distribution Channel, 2017 - 2028 (USD Million)
10.2.6. Australia Cannabis Inhalers Market Overview, 2017 - 2028 (USD Million)
10.2.6.1. Australia Cannabis Inhalers Market Overview, By Drug Type, 2017 - 2028 (USD Million)
10.2.6.2. Australia Cannabis Inhalers Market Overview, By Indication, 2017 - 2028 (USD Million)
10.2.6.3. Australia Cannabis Inhalers Market Overview, By Distribution Channel, 2017 - 2028 (USD Million)
10.2.7. Rest of Asia Pacific Cannabis Inhalers Market Overview, 2017 - 2028 (USD Million)
10.2.7.1. Rest of Asia Pacific Cannabis Inhalers Market Overview, By Drug Type, 2017 - 2028 (USD Million)
10.2.7.2. Rest of Asia Pacific Cannabis Inhalers Market Overview, By Indication, 2017 - 2028 (USD Million)
10.2.7.3. Rest of Asia Pacific Cannabis Inhalers Market Overview, By Distribution Channel, 2017 - 2028 (USD Million)

Chapter 11. South America Cannabis Inhalers Market Overview, By Countries, 2017 - 2028 (USD Million)
11.1. South America Cannabis Inhalers Market Overview, 2017 - 2028 (USD Million)
11.1.1. Market size and projections, 2017 - 2028 (USD Million)
11.1.2. South America Cannabis Inhalers Market Overview, By Drug Type, 2017 - 2028 (USD Million)
11.1.3. South America Cannabis Inhalers Market Overview, By Indication, 2017 - 2028 (USD Million)
11.1.4. South America Cannabis Inhalers Market Overview, By Distribution Channel, 2017 - 2028 (USD Million)
11.2. South America Cannabis Inhalers Market Overview, By Countries, 2017 - 2028 (USD Million)
11.2.1. Brazil Cannabis Inhalers Market Overview, 2017 - 2028 (USD Million)
11.2.1.1. Brazil Cannabis Inhalers Market Overview, By Drug Type, 2017 - 2028 (USD Million)
11.2.1.2. Brazil Cannabis Inhalers Market Overview, By Indication, 2017 - 2028 (USD Million)
11.2.1.3. Brazil Cannabis Inhalers Market Overview, By Distribution Channel, 2017 - 2028 (USD Million)
11.2.2. Argentina Cannabis Inhalers Market Overview, 2017 - 2028 (USD Million)
11.2.2.1. Argentina Cannabis Inhalers Market Overview, By Drug Type, 2017 - 2028 (USD Million)
11.2.2.2. Argentina Cannabis Inhalers Market Overview, By Indication, 2017 - 2028 (USD Million)
11.2.2.3. Argentina Cannabis Inhalers Market Overview, By Distribution Channel, 2017 - 2028 (USD Million)
11.2.3. Rest of South America Cannabis Inhalers Market Overview, 2017 - 2028 (USD Million)
11.2.3.1. Rest of South America Cannabis Inhalers Market Overview, By Drug Type, 2017 - 2028 (USD Million)
11.2.3.2. Rest of South America Cannabis Inhalers Market Overview, By Indication, 2017 - 2028 (USD Million)
11.2.3.3. Rest of South America Cannabis Inhalers Market Overview, By Distribution Channel, 2017 - 2028 (USD Million)

Chapter 12. Middle East & Africa Cannabis Inhalers Market Overview, By Countries, 2017 - 2028 (USD Million)
12.1. Middle East & Africa Cannabis Inhalers Market Overview, 2017 - 2028 (USD Million)
12.1.1. Market size and projections, 2017 - 2028 (USD Million)
12.1.2. Middle East & Africa Cannabis Inhalers Market Overview, By Drug Type, 2017 - 2028 (USD Million)
12.1.3. Middle East & Africa Cannabis Inhalers Market Overview, By Indication, 2017 - 2028 (USD Million)
12.1.4. Middle East & Africa Cannabis Inhalers Market Overview, By Distribution Channel, 2017 - 2028 (USD Million)
12.2. Middle East & Africa Cannabis Inhalers Market Overview, By Countries, 2017 - 2028 (USD Million)
12.2.1. GCC Cannabis Inhalers Market Overview, 2017 - 2028 (USD Million)
12.2.1.1. GCC Cannabis Inhalers Market Overview, By Drug Type, 2017 - 2028 (USD Million)
12.2.1.2. GCC Cannabis Inhalers Market Overview, By Indication, 2017 - 2028 (USD Million)
12.2.1.3. GCC Cannabis Inhalers Market Overview, By Distribution Channel, 2017 - 2028 (USD Million)
12.2.2. South Africa Cannabis Inhalers Market Overview, 2017 - 2028 (USD Million)
12.2.2.1. South Africa Cannabis Inhalers Market Overview, By Drug Type, 2017 - 2028 (USD Million)
12.2.2.2. South Africa Cannabis Inhalers Market Overview, By Indication, 2017 - 2028 (USD Million)
12.2.2.3. South Africa Cannabis Inhalers Market Overview, By Distribution Channel, 2017 - 2028 (USD Million)
12.2.3. Rest of Middle East & Africa Cannabis Inhalers Market Overview, 2017 - 2028 (USD Million)
12.2.3.1. Rest of Middle East & Africa Cannabis Inhalers Market Overview, By Drug Type, 2017 - 2028 (USD Million)
12.2.3.2. Rest of Middle East & Africa Cannabis Inhalers Market Overview, By Indication, 2017 - 2028 (USD Million)
12.2.3.3. Rest of Middle East & Africa Cannabis Inhalers Market Overview, By Distribution Channel, 2017 - 2028 (USD Million)


Chapter 13. Competitive Landscape
13.1. Competitive Environment, 2021
13.2. Strategic Framework
13.2.1. Partnership/Collaborations/Agreement
13.2.2. Expansion
13.2.3. Mergers & Acquisitions
13.2.4. New Product Development

Chapter 14. Key Vendor Analysis
14.1. Koi CBD
14.1.1. Business Overview
14.1.2. Product Benchmarking
14.1.3. Financial Data
14.1.4. Strategic Overview
14.1.5. Key Developments
14.1.6. SWOT Analysis
14.2. CBD Luxe
14.2.1. Business Overview
14.2.2. Product Benchmarking
14.2.3. Financial Data
14.2.4. Strategic Overview
14.2.5. Key Developments
14.2.6. SWOT Analysis
14.3. MÜV
14.3.1. Business Overview
14.3.2. Product Benchmarking
14.3.3. Financial Data
14.3.4. Strategic Overview
14.3.5. Key Developments
14.3.6. SWOT Analysis
14.4. Fairwinds Cannabis
14.4.1. Business Overview
14.4.2. Product Benchmarking
14.4.3. Financial Data
14.4.4. Strategic Overview
14.4.5. Key Developments
14.4.6. SWOT Analysis
14.5. Monarch Life Sciences LLC
14.5.1. Business Overview
14.5.2. Product Benchmarking
14.5.3. Financial Data
14.5.4. Strategic Overview
14.5.5. Key Developments
14.5.6. SWOT Analysis
14.6. Vapen Brands
14.6.1. Business Overview
14.6.2. Product Benchmarking
14.6.3. Financial Data
14.6.4. Strategic Overview
14.6.5. Key Developments
14.6.6. SWOT Analysis
14.7. Vectura Group plc
14.7.1. Business Overview
14.7.2. Product Benchmarking
14.7.3. Financial Data
14.7.4. Strategic Overview
14.7.5. Key Developments
14.7.6. SWOT Analysis
14.8. H&T Presspart Manufacturing Ltd.
14.8.1. Business Overview
14.8.2. Product Benchmarking
14.8.3. Financial Data
14.8.4. Strategic Overview
14.8.5. Key Developments
14.8.6. SWOT Analysis
14.9. Syqe Medical Ltd.
14.9.1. Business Overview
14.9.2. Product Benchmarking
14.9.3. Financial Data
14.9.4. Strategic Overview
14.9.5. Key Developments
14.9.6. SWOT Analysis

Chapter 15. Future Outlook of the Market
Disclaimer